Page last updated: 2024-09-04

olmesartan and Cerebrovascular Disorders

olmesartan has been researched along with Cerebrovascular Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kario, K; Kushiro, T; Mori, Y; Okuda, Y; Saito, I; Shimada, K; Teramukai, S; Yaginuma, M; Zenimura, N	1
Carvalho-Tavares, J; Castro-Faria Neto, H; Estato, V; Freitas, FS; Lessa, MA; Obadia, N; Reis, P; Tibiriçá, E	1
Hatanaka, K; Hirohata, A; Hirohata, S; Hirose, E; Ito, H; Kobayashi, Y; Komatsubara, I; Kusachi, S; Miyoshi, T; Ohara, M; Ohe, T; Ohkawa, K; Sano, F; Takafuji, H; Toyama, Y; Yamamoto, K; Yamawaki, H	1

Trials

1 trial(s) available for olmesartan and Cerebrovascular Disorders

Article	Year
Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial. Atherosclerosis, 2012, Volume: 220, Issue:1 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Cerebrovascular Disorders; Chi-Square Distribution; Coronary Artery Disease; Disease Progression; Disease-Free Survival; Female; Heart Diseases; Humans; Imidazoles; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2012

Article

Year

Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial.

Atherosclerosis, 2012, Volume: 220, Issue:1

Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Cerebrovascular Disorders; Chi-Square Distribution; Coronary Artery Disease; Disease Progression; Disease-Free Survival; Female; Heart Diseases; Humans; Imidazoles; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional

2012

Other Studies

2 other study(ies) available for olmesartan and Cerebrovascular Disorders

Article	Year
Home blood pressure and cardiovascular outcomes in very elderly patients receiving antihypertensive drug therapy: a subgroup analysis of Home blood pressure measurement with Olmesartan Naive patients to Establish Standard Target blood pressure (HONEST) st Clinical and experimental hypertension (New York, N.Y. : 1993), 2018, Volume: 40, Issue:5 Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Disorders; Female; Follow-Up Studies; Humans; Hypertension; Hypotension; Imidazoles; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Prospective Studies; Risk Factors; Risk Reduction Behavior; Systole; Tetrazoles	2018
Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats. Microvascular research, 2013, Volume: 87 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterial Pressure; Blood Glucose; Brain; Capillaries; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Circulation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet, High-Fat; Enalapril; Heart Ventricles; Hypertension; Imidazoles; Insulin; Leukocyte Rolling; Male; Microcirculation; Microscopy, Fluorescence; Microscopy, Video; Muscle, Skeletal; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Streptozocin; Tetrazoles	2013

Article

Year

Home blood pressure and cardiovascular outcomes in very elderly patients receiving antihypertensive drug therapy: a subgroup analysis of Home blood pressure measurement with Olmesartan Naive patients to Establish Standard Target blood pressure (HONEST) st

Clinical and experimental hypertension (New York, N.Y. : 1993), 2018, Volume: 40, Issue:5

Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Disorders; Female; Follow-Up Studies; Humans; Hypertension; Hypotension; Imidazoles; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Prospective Studies; Risk Factors; Risk Reduction Behavior; Systole; Tetrazoles

2018

Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.

Microvascular research, 2013, Volume: 87

Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterial Pressure; Blood Glucose; Brain; Capillaries; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Circulation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet, High-Fat; Enalapril; Heart Ventricles; Hypertension; Imidazoles; Insulin; Leukocyte Rolling; Male; Microcirculation; Microscopy, Fluorescence; Microscopy, Video; Muscle, Skeletal; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Streptozocin; Tetrazoles

2013